Joanna Kryst
Overview
Explore the profile of Joanna Kryst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kryst J, Chocyk A, Solarz-Andrzejewska A, Majcher-Maslanka I
Pharmacol Rep
. 2025 Mar;
PMID: 40063219
Background: Serotonin is strongly involved in the regulation of brain development, including the proper formation of neuronal circuits and synaptic plasticity. One of the factors that can affect brain serotonin...
2.
Czerwinska-Ledwig O, Zychowska M, Jurczyszyn A, Kryst J, Dzidek A, Zuziak R, et al.
Curr Oncol
. 2024 Dec;
31(12):7960-7970.
PMID: 39727710
Background: Multiple myeloma, a malignancy of plasma cells, often involves the disruption of vitamin D metabolism. Vitamin D, acting through its receptor (VDR), affects transcription factors like FOXO and sirtuins,...
3.
Kryst J, Matejko B, Czerwinska-Ledwig O, Tota L, Zuziak R, Piotrowska A
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685536
Dysregulation of matrix metalloproteinases (MMPs) activity is considered one of the potential causes of vascular complications in diabetic patients. Since training volume may influence MMPs levels in varying ways, the...
4.
Czerwinska-Ledwig O, Kryst J, Ziemann E, Borkowska A, Reczkowicz J, Dzidek A, et al.
Nutrients
. 2024 May;
16(10).
PMID: 38794651
The aim of the study was to assess the impact of two lengths of Nordic walking (NW) training interventions combined with time-restricted eating (TRE) on improving body-composition parameters, lipid profiles,...
5.
Czerwinska-Ledwig O, Zychowska M, Jurczyszyn A, Kryst J, Delag J, Borkowska A, et al.
J Clin Med
. 2024 May;
13(10).
PMID: 38792313
: Multiple myeloma (MM) accounts for about 10-15% of all diagnosed hematologic malignancies and about 1-2% of all cancer cases. Approximately 80-90% of MM patients develop bone disease and the...
6.
Solarz-Andrzejewska A, Majcher-Maslanka I, Kryst J, Chocyk A
Pharmacol Rep
. 2023 Feb;
75(2):293-319.
PMID: 36843201
Background: Early-life stress (ELS) affects brain development and increases the risk of mental disorders associated with the dysfunction of the medial prefrontal cortex (mPFC). The mechanisms of ELS action are...
7.
Solarz A, Majcher-Maslanka I, Kryst J, Chocyk A
Brain Behav Immun
. 2022 Nov;
108:1-15.
PMID: 36400335
Early-life stress (ELS) may affect brain maturation and neuroimmune interactions and, consequently, the inflammatory response to subsequent environmental factors later in life. Recently, the coexistence of blood-brain barrier (BBB) dysfunction...
8.
Kryst J, Majcher-Maslanka I, Chocyk A
Pharmacol Rep
. 2022 Sep;
74(5):920-946.
PMID: 36151445
Background: Drugs prescribed for psychiatric disorders in adolescence should be studied very extensively since they can affect developing and thus highly plastic brain differently than they affect the adult brain....
9.
Solarz A, Majcher-Maslanka I, Kryst J, Chocyk A
Neuroscience
. 2021 Mar;
463:238-253.
PMID: 33662529
Clinical studies clearly indicate that early-life stress (ELS) may cause physical and mental health problems later in life. Therefore, the identification of universal biomarkers of ELS-related diseases is very important....
10.
Kryst J, Kawalec P, Mitoraj A, Pilc A, Lason W, Brzostek T
Pharmacol Rep
. 2020 Apr;
72(3):543-562.
PMID: 32301056
Background: Due to unmet clinical needs for efficient drugs with a rapid onset of antidepressant effects, we aimed to evaluate the efficacy of single-dose ketamine in different subgroups of patients...